Can-Fite director reports option holdings
Can-Fite BioPharma Ltd. director Regev Guy filed an initial ownership statement showing direct holdings of options to purchase Ordinary Shares and a small number of shares.
Rhea-AI Filing Summary
Can-Fite BioPharma Ltd. director Regev Guy filed an initial ownership statement showing direct holdings of options to purchase Ordinary Shares and a small number of shares. He reports options over 16,000 shares at an exercise price of $2.18 per share plus several smaller, higher-priced option grants and 8 Ordinary Shares. The options were granted under the company’s share option plans, with some fully vested and others vesting in scheduled quarterly installments through 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Regev Guy
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options to Purchase Ordinary Shares — 20,548 contracts (Direct);
Ordinary Shares — 8 shares (Direct)
Footnotes (7)
- F1. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2003 Share Option Plan, 2013 Share Option Plan and 2023 Share Option Plan must be registered in the name of a trustee.
- F2. These options are fully vested and exercisable as of the date hereof.
- F3. The exercise price of this option, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 8,778, is presented in the table in U.S. dollars ("USD") based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00.
- F4. The exercise price of this option, originally denominated in NIS in the amount of NIS 750, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00.
- F5. The exercise price of this option, originally denominated in NIS in the amount of NIS 78.3, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00. Of the options reported herein 1,489 options are vested, and the remaining 1,489 options vest in five equal quarterly installments beginning 04/01/2026 and ending 04/01/2027 subject to the Reporting Person's continued service to the Issuer as of such vesting date.
- F6. The exercise price of this option, originally denominated in NIS in the amount of NIS 82.5, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00. Of the options reported herein 947 options are vested, and the remaining 1,219 options vest in nine equal quarterly installments beginning 05/07/2026 and ending 05/07/2028 subject to the Reporting Person's continued service to the Issuer as of such vesting date.
- F7. The exercise price of this option, originally denominated in NIS in the amount of NIS 6.767, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00. Of the options reported herein, none are vested, and all the 16,000 options vest in sixteen equal quarterly installments beginning 04/25/2026 and ending 01/25/2030 subject to the Reporting Person's continued service to the Issuer as of such vesting date.
Key Figures
Low-priced options: 16,000 options at $2.18
Option grant: 2,166 options at $26.56
Option grant: 2,166 options at $25.21
+3 more
6 metrics
Low-priced options
16,000 options at $2.18
Exercise price; options vest from 04/25/2026 to 01/25/2030
Option grant
2,166 options at $26.56
Exercise price; expiration 05/07/2034
Option grant
2,166 options at $25.21
Exercise price; expiration 04/30/2033
Option grant
200 options at $241.47
Exercise price; expiration 06/14/2030
Option grant
16 options at $2,826.14
Exercise price; expiration 11/08/2027
Ordinary Shares
8 shares
Directly held Ordinary Shares following the reported holdings
Key Terms
Section 102 of the Israeli Tax Ordinance, Share Option Plan, exercise price, vested, +1 more
5 terms
Section 102 of the Israeli Tax Ordinance financial
"To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee..."
exercise price financial
"The exercise price of this option, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 8,778..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vested financial
"Of the options reported herein 1,489 options are vested, and the remaining 1,489 options vest in five equal quarterly installments..."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Can-Fite (CANF) director Regev Guy report on this Form 3?
He reports his initial ownership in Can-Fite securities, mainly options to purchase Ordinary Shares plus 8 Ordinary Shares. The filing lists each option grant’s exercise price, expiration date, and vesting status under the company’s share option plans, establishing his baseline position.
How many Can-Fite (CANF) options at the lowest exercise price does Regev Guy hold?
He holds options over 16,000 Ordinary Shares at an exercise price of $2.18 per share. Footnotes state none of these options are vested yet and they vest in sixteen equal quarterly installments from 04/25/2026 through 01/25/2030, subject to continued service.
Are Regev Guy’s Can-Fite (CANF) options already vested or still vesting?
Some options are fully vested and exercisable, while others vest over time. For example, 1,489 of certain options are vested with the remainder vesting in five quarterly installments, and another grant vests in nine quarterly installments, all conditional on continued service with Can-Fite.
Why are Can-Fite (CANF) options held through a trustee under Section 102?
To qualify for specific Israeli tax benefits under Section 102 of the Israeli Tax Ordinance, employee securities under Can-Fite’s 2003, 2013, and 2023 Share Option Plans must be registered in a trustee’s name. This structure is tax-driven and does not change the reported economic interest.
What are the exercise prices of Regev Guy’s higher-priced Can-Fite (CANF) options?
He holds smaller grants with exercise prices of $2,826.14, $241.47, $25.21, and $26.56 per share. These prices were originally set in New Israeli Shekels and converted to U.S. dollars using a NIS 3.106 = USD 1.00 exchange rate.
AI-generated analysis. How Rhea-AI works. Not financial advice.
